Statin therapy is associated with lower mortality among patients with severe heart failure

American Journal of Cardiology - Tập 93 - Trang 1124-1129 - 2004
Dariush Mozaffarian1, Regina Nye2, Wayne C Levy3
1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, and the Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
2Pfizer PGRD, New London, Connecticut, USA
3Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA

Tài liệu tham khảo

American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, Texas: American Heart Association; 2001 Health Care Financing Administration. Heart Failure National Project Overview. Available at: http://www.hcfa.gov/quality/download/3s.pdf. Accessed May 12, 2001 1994, Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease, Lancet, 344, 1383 Sacks, 1996, The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. CARE Trial investigators, N Engl J Med, 335, 1001, 10.1056/NEJM199610033351401 1998, Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels, N Engl J Med, 339, 1349, 10.1056/NEJM199811053391902 Rauchhaus, 2000, The endotoxin-lipoprotein hypothesis, Lancet, 356, 930, 10.1016/S0140-6736(00)02690-8 De Pinieux, 1996, Lipid-lowering drugs and mitochondrial function, Br J Clin Pharmacol, 42, 333, 10.1046/j.1365-2125.1996.04178.x Marz, 2000, Effects of lovastatin and pravastatin on the survival of hamsters with inherited cardiomyopathy, J Cardiovasc Pharmacol Ther, 5, 275, 10.1054/JCPT.2000.16695 Ridker, 2001, Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia, Circulation, 103, 1191, 10.1161/01.CIR.103.9.1191 Holm, 2001, Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients, Am J Cardiol, 87, 815, 10.1016/S0002-9149(00)01516-2 Palinski, 2002, Immunomodulatory effects of statins, J Am Soc Nephrol, 13, 1673, 10.1097/01.ASN.0000018400.39687.8C Node, 2003, Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy, Circulation, 108, 839, 10.1161/01.CIR.0000084539.58092.DE Kapadia, 1998, The role of cytokines in the failing human heart, Cardiol Clin, 16, 645, 10.1016/S0733-8651(05)70041-2 Blum, 2001, Pathophysiological role of cytokines in congestive heart failure, Annu Rev Med, 52, 15, 10.1146/annurev.med.52.1.15 Packer, 1996, Effect of amlodipine on morbidity and mortality in severe chronic heart failure. PRAISE Study Group, N Engl J Med, 335, 1107, 10.1056/NEJM199610103351504 O'Connor, 1998, Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial, Am J Cardiol, 82, 881, 10.1016/S0002-9149(98)00496-2 Jones, 1998, Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study), Am J Cardiol, 81, 582, 10.1016/S0002-9149(97)00965-X Rosenbaum, 1983, The central role of the propensity score in observational studies for causal effects, Biometrika, 70, 41, 10.1093/biomet/70.1.41 Horwich, 2002, Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure, J Card Fail, 8, 216, 10.1054/jcaf.2002.0804216 Mitchell, 2003, Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial, J Am Coll Cardiol, 42, 81, 10.1016/S0735-1097(03)00498-4 Tracy, 1997, Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects, Arterioscler Thromb Vasc Biol, 17, 2167, 10.1161/01.ATV.17.10.2167 Bauersachs, 2001, Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction, Circulation, 104, 982, 10.1161/hc3401.095946 Hayashidani, 2002, Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction, Circulation, 105, 868, 10.1161/hc0702.104164 Pliquett, 2003, Simvastatin normalizes autonomic neural control in experimental heart failure, Circulation, 107, 2493, 10.1161/01.CIR.0000065606.63163.B9 Kjekshus, 1997, The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease, J Card Fail, 3, 249, 10.1016/S1071-9164(97)90022-1